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Abstract
Objectives: Schizophrenia (Sch) is a severe and chronic mental illness. Smoking prevalence is higher in patients with Sch than general population. We aimed 
to investigate the effects of MAOB gene A644G variant on nicotine dependence (ND) and Sch+ND risk in Turkish population and to evaluate by bioinformatic 
analysis. Methods: Present study included 161 individuals with ND, 223 patients with Sch+ND, and 96 non-smoker controls. MAOB A644G variant was 
analyzed using PCR-RFLP method. As the MAOB gene is located on the X chromosome, each gender was analysed separately. Results: The total distributions 
of AA, AG and GG genotypes of MAOB gene A644G were 44.7%, 22.4% and 32.9% in the ND group, 45.3%, 25.1% and 29.6% in the Sch+ND group and, 44.8, 
22.9% and 32.3% in non-smoker controls. No significant differences were observed between groups for the MAOB A644G genotype and allele frequencies 
when female group compared to male group (p > 0.05). Examination of disease associations of SNPs from each miRNA gene region in GWAS databases 
yielded results for aging, bipolar disorder, autoimmune, and neurological diseases. Discussion: Our results indicate that the MAOB gene A644G variant is 
not associated with ND and/or Sch susceptibility in the Turkish population.
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Introduction
Schizophrenia (Sch) is a chronic and severe mental disorder with an 
elusive psychopathology. This disease can be extremely devastating and 
interferes with cognition, emotion, perception, and other behavioral 
aspects1. Inheritance has been found in up to 80% of the cases2, however, 
the exact etiology of this disorder is still unclear. Many researchers 
have proposed that dysregulated dopaminergic neurotransmission is 
involved in the pathogenesis3. Dopamine acts as a neurotransmitter 
by binding to its specific receptors on the postsynaptic membrane and 
autoreceptors on the presynaptic membrane. 
Tobacco use is the only most preventable cause of death, disability 
and illness in the World. Nicotine, the major active component 
of cigarettes that plays a role in physical dependence, influences 
nicotine receptors in the central nervous system and results in the 
release of neurotransmitters (including dopamine). Nicotine activates 
dopaminergic neurons in the mesolimbic reward system and induces 
dopamine release4. The prevalence of smoking is much higher among 
people with psychotic disorders compared to the general population. 
Besides, among those suffering from Sch, the nicotine dependence 
(ND) occurs more frequently than both the general population and 
those with other psychiatric diseases5.
Genes that play a role in neurotransmitter metabolism 
pathways have been widely examined in studies of psychiatric 
disorders.  Monoamine oxidase (MAO; E.C. 1.4.3.4) is a flavin-
adenine-dinucleotide (FAD)-containing enzyme that plays a role in 
the metabolic breakdown of several biogenic amines6. It is found on the 
outer membrane of mitochondria in most cell types. Two isoenzymes 
(MAOA and MAOB) of MAO are present. In humans, MAOA 
ideally oxidizes serotonin and noradrenaline, while MAOB oxidizes 
dopamine7. MAOA and MAOB genes are sequenced tail to tail on the 
Xp11.23 chromosomal region, and both genes have 15 homologous 
exons (1). A644G single nucleotide polymorphism (SNP) (rs1799836) 
in intron 13 of the MAOB is known functional polymorphism8. 
Therefore, we conducted a case-control study in a Turkish 
population, to assess the impact of the MAOB A644G variant on 
risk ND and/or Sch+ND. As the MAOB gene is located on the X 
chromosome, each gender was analyzed separately.
Methods
Study population
The study sample included 161 subjects with ND (87 male and 74 
female; mean age: 45.93 years), 223 subjects with Sch+ND (105 
male and 118 female mean age: 46.78 years), and 96 unrelated 
healthy controls (41 male and 55 female; mean age: 44.91 years). 
The ethnicity of all participants was Turkish. The patients with 
Sch were recruited from the Department of Psychiatry Clinic, 
Bakirkoy Mental Health Research and Training Hospital, Istanbul, 
Turkey and diagnosed according to the Diagnostic and Statistical 
Manual of Mental Disorders, 4th ed. (DSM-IV)9. ND group was 
selected from the Department of Chest Diseases, Yedikule Hospital 
for Chest Diseases and Thoracic Surgery Training and Research 
Hospital, Istanbul, Turkey. ND group consisted of active smokers. 
These subjects were defined as those who had previously smoked 
more than one cigarette per day but had quit smoking for more 
than one year. The degree of ND was evaluated by the scores on 
Heaviness of Smoking Index (HSI) and the Fagerström Test for 
Nicotine Dependence (FTND)10. Control group was recruited from 
“non-smokers” were defined as those who had smoked less than 
one cigarette per day for no more than 1 year during their lifetime. 
Before enrollment, signed informed consent was obtained from 
every participant or their guardians if the participant was a minor 
or could not provide consent. The study protocols were performed 
according to the principles of the Declaration of Helsinki. This study 
was approved by the Ethics Committees of the Istanbul University, 
Istanbul Medical Faculty.
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Genotyping
Blood samples were collected from all participants using EDTA tubes 
and DNA was extracted from whole blood using salting out method11. 
DNA samples were stored at-20 °C until genotype analysis. The 
MAOB A644G variant was analyzed by polymerase chain reaction 
(PCR) and restriction fragment length polymorphism (RFLP) 
assays12. The segment was replicated by using the following forward 
and reverse PCR primers: 5-GGAACCTCTTATACCACAGG-3 
and 5-GACTGCCAGATTTCATCCTC-3. Then the DNA products 
was digested with the restriction enzyme Tsp 45I. MAOB allele 1 
(containing A and therefore the Tsp 45I restriction site) was detected 
as two bands of 146 and 86 bp, whereas allele 2 (containing G and no 
Tsp 45I restriction site) was detected as a single 232-bp band. Since 
the MAOB gene is found on the X chromosome, i.e. males carry only 
one allele for MAO-B.
Bioinformatic analysis
We examined the regulation of expression of MAOB (microRNAs 
(miRNAs); co-regulated gene sets), and disease associations of 
MAOB sequence variants. Gene co-expression networks can be used 
to associate genes of unknown function with biological processes, 
to prioritize candidate disease genes. We used the CO-Regulation 
Database (CORD) for co-expression analysis, GSEA/MSigDB for 
gene enrichment analysis, TargetScan for miRNAs targeting MAOB 
and GRASP as GWAS Database for disease associations of MAOB 
and miRNA region SNPs. Also, we used13 for enhancers effecting 
MAOB expression and other genes.
Statistical analysis
The genotype distribution and allele frequency of the MAOB 
A644G variant in the control and patient groups were compared 
using Chi-squared tests. The Hardy-Weinberg equilibrium (HWE) 
was calculated using the de Finetti program (Online HWE and 
Association Testing-Institut für Humangenetik, Munich, Germany). 
Odds ratio (OR) and 95% confidence intervals (CIs) were estimated 
using the binary logistic regression method. p values less than 0.05 
were considered statistically significant.
Results
In the present study, a total of 480 subjects, including 161 subjects 
with ND, 96 non-smoker control, and 223 patients with Sch+ND 
were genotyped for the A644G variant of MAOB gene. The genotype 
and allele frequencies of the MAOB A644G variant in the studied 
groups was shown in table  1. There were 74 (45.9%) female and 
87 (54.1%) male in the ND group and 55 (57.3%) female and 41 
(42.7%) male in the control group (non-smoker) and 118 (52.9%) 
female and 105 (47.1%) male in Sch+ND group. The prevalence of 
total genotypes of AA/A, AG, and G/GG profiles for MAOB A644G 
variant were 44.7%, 22.4% and 32.9% respectively in the ND group, 
44.8%, 22.9%, and 32.3% in non-smoker group, and 45.3%, 25.1% 
and 29.6% in the Sch+ND group.
The statistically significant relationship was not found between 
groups for the MAOB A644G genotype and allele frequencies 
(p > 0.05). 
Discussion
Sch has been considered as a complex neurodevelopmental disorder. 
The brain’s monoamine (dopamine, serotonin and norepinephrine) 
systems are involved in normal behavior and pathology within these 
circuits is suggested to underlie several neurological and psychiatric 
conditions. Dopamine neurons in the midbrain manifest various 
unique activity states that have implications for the function of 
the dopamine system. A dopamine hypothesis of Sch proposes a 
final common pathway of presynaptic striatal hyperdopaminergia 
resulted by an interaction between numerous environmental and 
genetic risk factors influencing brain function that lead to negative 
and cognitive symptoms3. 
Table 1. Genotype and allele frequencies of MAOB A644G variant in ND, control and Sch+ND groups
MAOB A644G Genotypes ND 
group
Control 
group
Sch+ND group OR %95 CI* p
n (%) n (%) n (%)
Females A/A 24 (32.4) 17 (30.9) 41 (34.7) 1.030 0.751-1.413 0.854p1
0.887 0.550-1.429 0.753p2
0.937 0.638-1.377 0.862p3
A/G 36 (48.7) 22 (40.0) 56 (47.5) 1.160 0.862-1.559 0.425p1
0.812 0.518-1.272 0.451p2
1.031 0.720-1.472 0.990p3
G/G 14 (18.9) 16 (29.1) 21 (17.8) 0.770 0.508-1.165 0.208p1
1.508 0.957-2.376 0.136p2
1.047 0.666-1.645 0.849p3
Males A 48 (55.2) 26 (63.4) 60 (57.1) 0.898 0.709-1.137 0.491p1
G 39 (44.8) 15 (36.6) 45 (42.9) 1.209 0.702-2.082 0.613p2
0.957 0.700-1.308 0.898p3
Total A/A+A* 72 (44.7) 43 (44.8) 101 (45.3) 0.858 0.718-1.025 0.117p1
0.986 0.704-1.380 0.994p2
0.939 0.743-1.189 0.679p3
A/G 36 (22.4) 22 (22.9) 56 (25.1) 0.998 0.786-1.241 0.917p1
0.918 0.614-1.373 0.782p2
0.914 0.685-1.218 0.616p3
G/G+G* 53 (32.9) 31 (32.3) 66 (29.6) 1.011 0.728-1.235 0.915p1
1.092 0.765-1.557 0.728p2
1.093 0.853-1.400 0.559p3
ND: Nicotine dependence; Sch: schizophrenia; P1: ND versus control; P2: ND versus Sch+ND; P3: control versus Sch+ND. * The genotype distribution of MAOB A644G variant were compared as female, 
male and total (female+male) groups.
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Smoking is commonly encountered in Sch cases and it is one of 
the main causes of early death in this illness. Even though causes for 
such high frequency of cigarette smoking in patients with Sch remain 
unclear, dopamine seems to play a crucial role in this correlation. It 
has been shown that the addictive effects of smoking are not limited 
to the effects of nicotine, but may also be associated with the high 
dopamine levels14. Nicotine elevates dopamine levels in striatum 
by inducing its release via nicotinic receptors, and diminishing its 
breakdown by hindering monoamine oxidase type A and B15. Due to 
crucial role of dopamine in ND, variants in several dopamine related 
genes have been suggested and examined for their potent relations 
with smoking behaviour.
MAO catalyses the oxidative deamination of numerous biogenic 
amines, and is involved in the regulation of neurotransmitters 
in the central nervous system, such as modulation of synaptic 
concentrations of serotonin, dopamine, norepinephrine and other 
catecholaminergic neurotransmitters. Enhancers affecting MAOB 
expression and other genes: [EFHC2 (EF-hand domain containing 2) 
and MAOA are also targeted by the same enhancers affecting MAOB 
expression]. An important paralog of this gene is MAOA. When 
5-fold threshold was used, there were 192 concordantly co-expressed 
genes. (PHYH, ALDH6A1, RGN, FXYD1, MLXIPL, ISOC1, DDO, 
GSTM4, SLC6A12, AMACR, CRP, FLJ39378, FLJ21963). Using 
TargetScan we selected the miRNAs targeting MAOB with a context 
score of less than -0.30, and determined their other target genes. 
Altogether, 26 miRNAs were identified as targeting MAOB16. 
Variations in MAO enzyme expression and activity may 
contribute to genetic susceptibility for becoming a smoker, and could 
affect the ability of a smoker to quit. MAOB A644G variant leads to 
a transitional conversion from adenine (A) to guanine (G) 36 bp 
upstream from the 5’-end of exon 14. It is proposed that, because 
of its position,  this variant alters the stability and/or translation 
of  MAOB  mRNA17. Studies have been previously conducted 
to investigate the relation with smoking for polymorphisms of 
dopamine metabolic enzymes. Ito et al. found a decreased risk of 
being current smokers for individuals carrying the 4-repeat allele 
of the MAOA VNTR polymorphism in the promoter region for 
women, and the results were the opposite for men18. Costa-Mallen 
et al. suggested that MAOB G644A was not associated with smoking 
status in either men or women, however, they reported that there was 
an interaction between MAOB A644G and the D2 dopamine receptor 
(DRD2) gene TaqIB variants; they also proposed that subjects 
carrying MAOB allele A and genotype B12 of DRD2 were 2.50 times 
more likely to be ever-smokers than the pool of men carrying all 
other genotype combinations19. Fowler et al. showed that both type 
A and type B MAO are inhibited in the brains of smokers20. Also, 
it was found a significant association between the MAOB intron 13 
allele and different levels of MAOB enzyme activity in human brain17. 
Tiili et al. reported that the MAOB intron 3 AG variant G allele was 
more prevalent in female smokers than non-smokers21. Also, it was 
reported that A allele in MAOB  G644A variant reduced the risk 
of heavy smoking in males22. However, Tochigi et al. obtained no 
evidence for an association between the MAO genes and smoking 
behavior, including epistatic or additive effects23.
There are several studies suggest that  MAO  genes may be 
implicated in the susceptibility to Sch. Investigated MAOA gene 
variants mostly haven’t been linked with Sc24-25. For MAOB A644G 
variant and Sch, a sex specific association has been found in 
Spanish population, with a high prevalence of G allele in women 
diagnosed with Sch compared to healthy women controls26. 
Although Peitl et al. reported that MAOA VNTR variant did not 
reveal statistically significant findings in overall samples, they found 
that MAOA VNTR variant allele 3 was statistically more frequent 
in male patients with Sch27. Bergen et al. reported that there was 
an association between a  MAOB microsatellite polymorphism 
and particular clinical features of patients with Sch28. In studies 
investigating Sch symptoms, Camarena was found that there were 
statistical differences between MAOB A644G variant and affective 
flattening scores in patients with Sch29. But Zammit et al. supported 
that genotypes of MAOA and MAOB genes are not risk factors for 
aggressive behavior in Sch30. 
In present study, we investigated the possibility that MAOB A644G 
variant may also be involved in predisposition to ND and ND+Sch. 
Since the MAOB gene is found on the X chromosome, each gender 
was usually analyzed for both genders. To the best our knowledge, 
this is the first association study of MAOB gene A644G and ND and/
or Sch risk in a Turkish population. The our results did not show the 
significant association between the genotype/allele frequencies of the 
MAOB A644G variant and ND and/or Sch+ND risk.
The present study, however, bear some limitations. First, the 
findings may be limited to the Turkish population. Ethnic variations 
may also play a role in association studies. We could not determine 
MAOB expression. Another limitation is that Sch subgroups are 
not specified. Furthermore, the present study has a relatively small 
population size and may not have the necessary strength. Therefore, 
larger sample sizes are needed to identify smaller effects, possibly of 
little clinical significance. 
In conclusion, our preliminary findings could indicate the MAOB 
A644G variant was not associated with ND and/or Sch+ND risk in a 
Turkish cohort. The complex nature of psychiatric illnesses mandates 
a multidisciplinary approach involving genetics, neuroscience, 
psychiatry, and molecular biology in order to achieve a final 
conclusion. As for now, we suggest that further large-scale studies 
should be conducted to clarify the role of this gene in ND and Sch 
pathogenesis to obtain more insight into this hypothesis.
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